All lobbying filings

Caredx, Inc.

Caredx, Inc. filed a Q4 report for Caredx, Inc. on January 20, 2026.

Lobbying for Caredx, Inc. · Clinical laboratory and transplant support services

As filed: CAREDX, INC. for CAREDX, INC.

All filings by Caredx, Inc. · Everything Caredx, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$110,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Lobbyists on this filing 1

KIMBERLY LINTHICUM

Previously held: LD, Rep. Bob Franks

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

-Medicare coverage of molecular testing for solid organ allograft rejection -Medicare payment of clinical laboratory tests; implementation of Sec 216 of the Protecting Access to Medicare Act of 2014 (PL 113-93) and RESULTS Act (HR5269) -Prior authorization of molecular tests

Bills named in this filing 1

H.R. 5269
RESULTS Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.